Other languages Paxman AB

Equities

PAX

SE0009806284

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
55 ^SEK	+0.73%		+17.02%	+49.46%

Jun. 29	Paxman AB Announces Presentation of Important Preliminary Data in Cryotherapy Side-Effect Management for Safety & Efficacy of Paxman Limb Cryocompression Device	CI
May. 23	Paxman AB Appoints Karen Giddings Clakely to the Board	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Paxman AB Announces Presentation of Important Preliminary Data in Cryotherapy Side-Effect Management for Safety & Efficacy of Paxman Limb Cryocompression Device	Jun. 29
Paxman AB Appoints Karen Giddings Clakely to the Board	May. 23
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 23
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 14
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	23-10-03
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24
Paxman AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-24
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-24
Paxman Scalp Cooling System Receives EU MDR Certification	23-01-26
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-18
Paxman AB Announces Its Selection by the SWOG Cancer Research Network for the Paxman Limb Cryocompression System to Be Used in A Prospectively Designed Study Looking At Prevention of Chemotherapy-Induced Peripheral Neuropathy	22-11-15
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-24
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-25
Paxman Launches Enhanced Provider and Patient Assistance Services, as Well as Offering A New Business Model to Health Systems	22-05-09
Paxman AB Signs Letter of Interest with Guangzhou Concord Medical Sci-Tech Innovation Center Co. Ltd. to Enter into Distribution and Marketing Agreement	22-04-12
Paxman AB Signs New Distribution Agreement with Partner in Serbia	22-03-30
Paxman AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-25
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Paxman AB

Equities

PAX

SE0009806284

Other languages

Filters